Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the ISBP 2022 Conference
15 sept. 2022 16h20 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science...
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the CROPS 2022: Improving Agriculture Through Genomics Conference
15 juin 2022 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science...
Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic
08 mars 2022 08h30 HE
|
Yield10 Bioscience, Inc.
-Acre-scale seed production planned in spring 2022 -First winter PHA Camelina planting expected in fall 2022 -Research program to produce PHA co-polymers is underway WOBURN, Mass., March 08, 2022...
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
31 janv. 2021 19h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 31, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering of...
Yield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
19 janv. 2021 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced successful field testing of prototype lines of the...